Ulcerative Colitis Clinical Trials in Indianapolis, Indiana

3 studies are recruiting for ulcerative colitis in Indianapolis, Indiana right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

    The main purpose of this study is to show whether in these individuals, treatment with both mirikizumab and tirzepatide, compared with treatment with mirikizumab and placebo, leads to decrease or disappearance of UC symptoms, and loss of at least one-tenth of the overall body weight. Participation …

    Stage
    Phase 3
    Ages
    18 to 70
    Site
    Indiana University Health University Hospital, Indianapolis, Indiana
    Locations
    187 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT06937086 on ClinicalTrials.gov

  2. A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)

    The study is an extension of two parent studies (MLN0002-3024 [NCT04779307] and MLN0002-3025 [NCT04779320]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.

    Stage
    Phase 3
    Ages
    2 and older
    Site
    Riley Hospital For Children - PIN, Indianapolis, Indiana
    Locations
    98 in total
    Run by
    Takeda

    See if you can join NCT05442567 on ClinicalTrials.gov

  3. Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis

    This is a randomized, double-blind, placebo-controlled, multicenter, study to evaluate the efficacy, safety, and pharmacokinetics (PK) of budesonide extended-release tablets for the induction of remission in pediatric subjects, with active, mild to moderate ulcerative colitis (UC). Subjects will be…

    Stage
    Phase 4
    Ages
    5 to 17
    Site
    Bausch Health Site 003, Indianapolis, Indiana
    Locations
    4 in total
    Run by
    Bausch Health Americas, Inc.

    See if you can join NCT04314375 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.